Insilico Medicine founder and CEO Alex Zhavoronkov, PhD attends AAIH Annual Members’ Meeting

EurekAlert!·Sep 27

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

Insilico Medicine's founder and CEO, Alex Zhavoronkov, has been attending various conferences and events. The company's leadership is also participating in several other meetings and exhibitions, including the J.P. Morgan Healthcare Conference and the LEAP EAST exhibition. Insilico Medicine is showcasing its advances in AI-driven drug discovery at these events.

Full coverage

Insilico Medicine leadership to attend 44th Annual J.P. Morgan Healthcare Conference

Insilico Medicine·Jan 8

Insilico Medicine CEO Alex Zhavoronkov to speak on longevity and AI in healthcare at Fortune Global Forum in Riyadh

Insilico Medicine·Oct 24

Dr. Alex Zhavoronkov, Founder and CEO of Insilico Medicine, has been invited to attend the international science, technology, and information technology exhibition, LEAP EAST, held in Hong Kong from July 8 to 10.

EurekAlert!·Jul 3

Join Insilico Medicine at NeurIPS 2025: Unveiling generative AI breakthroughs revolutionizing drug discovery and development

Insilico Medicine·Dec 1

Weekly Conferences | From San Diego to Shanghai: Insilico Medicine showcases new advances in AI-driven drug discovery

EurekAlert!·Jun 18

Insilico Medicine shines at International Executive Summit, sharing the journey from tech innovation to clinical validation in AI drug discovery